Journal of Natural Products · 2001 · 377 citations · 8 references
MedicineMedicinal ChemistryPharmacologyDrug DiscoveryMarine MicrobiologyPlant BiochemistryAntitumor AntibioticsEnzyme InhibitionMarine Bioactive CompoundsMarine Natural ProductsMarine PharmacologyMicrotubule-targeting AgentsAnticancer Marine CompoundsBioactive Compounds From Marine FungiBiological Evaluation ReportMarine-derived Anticancer Compounds
The potent antitumor agent dolastatin 10 (1) was originally isolated from the sea hare Dolabella auricularia, and we now report its isolation from the marine cyanobacterium Symploca sp. VP642 from Palau. The chemically related analogue symplostatin 1 (2) has been reisolated from Guamanian and Hawaiian varieties of S. hydnoides and its total stereochemistry completed by determining the N,N-dimethylisoleucine unit to be L. Symplostatin 1 (2), like dolastatin 10 (1), is a potent microtubule inhibitor. The antitumor activity of 2 was assessed in vivo against several murine tumors. Symplostatin 1 (2) was effective against a drug-insensitive mammary tumor and a drug-insensitive colon tumor; however, it was only slightly effective against two MDR tumors.
8
New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening
Philip Skehan, Ritsa Storeng, Dominic A. Scudiero et al. · JNCI Journal of the National Cancer Institute · 1990 · 9.8K citations
Medicine, Oncology, Pharmacology +10
Progress in the chemistry of organic natural products
Gerhard Habermehl · Toxicon · 1983 · 541 citations
Pharmacy, Biochemistry, Chemistry +12
Isolation of dolastatins 10–15 from the marine mollusc
George R. Pettit, Yoshiaki Kamano, Cherry L. Herald et al. · Tetrahedron · 1993 · 159 citations